NTM (Next Twelve Months)
A forward-looking metric representing projected performance over the next 12 months — used in valuation when historical performance materially understates current or expected trajectory. NTM revenue and EBITDA multiples are common in high-growth sectors (SaaS, tech-enabled services) where historical TTM/LTM figures don't capture run-rate. Buyers resist NTM-based valuations because projections are inherently less reliable than actuals. Sellers can argue for NTM when there are documented, recent business changes (new contracts, launched products) that aren't fully in TTM.
Full Definition
NTM (Next Twelve Months) refers to financial projections or metrics for the upcoming 12-month period from the current date, as opposed to LTM (Last Twelve Months), which covers the prior 12 months of actual results. In M&A and investment analysis, NTM metrics are used when a business is growing rapidly and historical (LTM) figures understate the current run rate — making forward-looking NTM figures a more relevant basis for valuation. Applying a valuation multiple to NTM revenue or EBITDA is common for high-growth software, SaaS, and technology businesses.
The distinction between LTM and NTM matters because of business trajectory. A business that grew from $8M to $12M ARR in the past 12 months and is currently at a $12M ARR run rate has an LTM ARR of approximately $10M (average of the period) but an NTM ARR of $14-16M (if growth continues at a similar pace). Valuing this business at 6x LTM ARR ($60M) vs. 6x NTM ARR ($84-96M) produces dramatically different implied enterprise values. Which is the right basis depends on how credible the growth projection is.
NTM multiples are particularly common in PE and venture capital analysis where buyers are paying for future earnings power rather than current earnings. When a buyer underwrites a 50% revenue growth rate, applying a multiple to NTM revenue effectively gives credit for growth that hasn't yet occurred — which is justified if the growth is highly probable but creates risk if projections don't materialize. Buyers who base their acquisition price on NTM metrics have limited downside protection if the business grows slower than projected.
In practice, sophisticated M&A buyers typically use a blend of LTM and NTM analysis: LTM validates current performance; NTM projects the trajectory. Discrepancies between LTM and NTM — a business with 5% LTM growth but 30% NTM projections — require specific explanation and due diligence validation. What has changed that makes the next 12 months dramatically better than the last 12 months?
For SMB M&A, NTM analysis is most relevant for businesses in high-growth phases: early-stage SaaS companies, rapidly expanding services businesses, or businesses that have recently signed major contracts that will drive significant near-term revenue growth. For mature, stable businesses, the difference between LTM and NTM is small and LTM analysis is typically sufficient.
Seller vs. Buyer Perspective
Present your business on both LTM and NTM bases when marketing to buyers. If your business is in a growth phase, NTM metrics tell the more compelling story — but they must be backed by concrete evidence, not aspirational projections. Support your NTM forecasts with: signed customer contracts, pipeline data with conversion rate history, backlog information, and specific initiatives with identifiable revenue impact. Buyers who cannot validate NTM projections will discount to LTM.
For businesses with significant seasonality, ensure that NTM projections account for seasonal patterns accurately. A business that does 40% of annual revenue in Q4 has very different NTM projections depending on whether the current date is Q1 or Q3. Present seasonality-adjusted projections rather than simple straight-line growth from current run rate.
Beware of committing to NTM projections in marketing materials that you cannot subsequently support in diligence. Buyers who find that the business is tracking materially below NTM projections during the diligence period have grounds to reprice or exit. Only present NTM projections you genuinely believe are achievable.
Apply significant skepticism to NTM projections in seller-provided materials — particularly for businesses where management is the source of growth assumptions. Request the specific contracts, pipeline, or initiatives that support each revenue growth assumption. Pipeline data should be supported by CRM data with deal stage, probability weighting, and timeline estimates.
For businesses valued on NTM EBITDA, model what the acquisition price implies if growth falls to 70%, 50%, or 25% of projected NTM. The effective entry multiple on the downside scenario tells you the true risk you're accepting. An acquisition that looks like 8x NTM EBITDA at 30% growth becomes 12x LTM EBITDA at 0% growth — a very different risk profile.
NTM analysis is most defensible when supported by contracted or committed revenue. A SaaS business with 90% of NTM revenue already under contract is a fundamentally different proposition from one whose NTM projections depend on winning new logos. Model the contracted vs. projected components separately to understand your risk exposure.
Real-World Example
A managed IT services company has $4.8M ARR at the current measurement date, representing 40% growth from $3.4M ARR a year prior. LTM ARR (average of trailing 12 months) is approximately $4.1M. NTM ARR (projecting continued 40% growth) is approximately $6.7M. A PE firm values the business at 6x NTM ARR: $40.2M. At 6x LTM ARR, the value would be $24.6M. At 6x current run-rate ARR, the value would be $28.8M. The PE firm's willingness to use NTM ARR reflects their conviction in the growth trajectory — confirmed by a signed 3-year contract with a major new client representing $800K ARR that begins next quarter. That contracted revenue makes the NTM projection credible enough to underwrite.
Why It Matters & Common Pitfalls
- !NTM projections without support. Applying a multiple to NTM metrics that aren't supported by contracts, pipeline evidence, or specific initiatives is speculation. Require sellers to provide specific substantiation for all NTM growth assumptions.
- !Ignoring seasonality in NTM modeling. Businesses with significant seasonality require careful period-selection when defining NTM. A Q4-heavy business measured at Q1 start will have very different NTM projections than one measured at Q3 start.
- !NTM vs. run rate confusion. NTM (projected next 12 months) is different from current annualized run rate (current month × 12). For growing businesses, run rate represents where the business IS; NTM represents where it will be on average over the next year. Clarify which metric is being used.
- !Double-counting growth in price. Paying a high multiple on NTM metrics AND paying for accelerated growth in the financial model double-counts growth. Either pay a lower multiple on NTM, or use a base-case conservative NTM with upside scenarios modeled separately.
Frequently Asked Questions
What is NTM in M&A?↓
Should I value my business on NTM or TTM?↓
Related Terms
LTM (Last Twelve Months)
A financial measurement covering the most recent 12 complete months of business — used for EBITDA, revenue, and other metrics as the denominator in valuation multiples. Essentially synonymous with TTM (Trailing Twelve Months).
TTM (Trailing Twelve Months)
Financial measurement covering the most recent 12 completed months — used as the denominator in M&A valuation multiples. Synonymous with LTM (Last Twelve Months).
Valuation Multiple
The ratio between enterprise value and a financial metric — typically EBITDA — used to express what a business is worth in comparable terms. The primary language of SMB/LMM M&A pricing.
Adjusted EBITDA
EBITDA recalculated to remove one-time, non-recurring, or owner-specific expenses so buyers can see the true recurring earnings power of a business.
Get Weekly M&A Insights
Valuation data, deal analysis, and plain-English M&A education — every week.
The LegacyVector Newsletter
Join 5,000+ business owners, investors, and buyers who get weekly M&A market data and deal insights.
- Weekly valuation multiples by industry
- SBA lending rates & deal financing data
- Market trends & acquisition opportunities
No spam. Unsubscribe anytime. Free forever.
Disclaimer: The information provided on this page is for educational and informational purposes only. It should not be considered financial, legal, or investment advice. Business valuations depend on many factors specific to each situation. Always consult with qualified professionals — including business brokers, CPAs, and M&A attorneys — before making acquisition or sale decisions. LegacyVector is not a licensed broker, financial advisor, or attorney. Data shown may be based on limited samples and may not reflect current market conditions.
LegacyVector Research Team
Reviewed by M&A professionals · Updated April 2026